Search

everythinglearnresearchcommunity

for

Search:↓

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Genetic variants in specific genes cause central centrifugal cicatricial alopecia.

Certain genetic variants reduce enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

LGR5 and LGR6 are expressed differently in various skin tumors, which may offer clues about their origins.

Bicalutamide mesotherapy may help with hair loss and seborrhea but needs more research.

miR-203a-3p helps hair follicle stem cells become specialized by targeting Smad1.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.

Neutrophils quickly respond to skin injury.

Calretinin identifies the companion cell layer in human hair follicles.

Arabidopsis Formin 2 stabilizes actin filaments to aid cell-to-cell trafficking.

Cinchonine Nanostructured Lipid Carriers serum safely and effectively stimulates hair growth and increases the number and size of hair follicles.

CD133+ cells are crucial for hair growth.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Cystatin M/E helps in the final stages of hair and nail formation by controlling certain enzymes.

Activin A and follistatin control when hair cells develop in mouse ears.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

LPA3 signaling in the uterus is crucial for placental formation and fetal development.

Enzymes can release hydrocarbons from Botryococcus braunii without harming cells, suggesting potential for continuous extraction.

Histone H4, released by cells exposed to colchicine, can cause hair loss by inhibiting cell growth and enzyme activity.

Two new gene mutations cause a rare hair disorder.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Basal cell carcinoma behaves like hair follicles and targeting specific pathways may help treat it.

The HtrA1L364P mutation causes brain dysfunction and blood vessel damage.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

Cepharanthine may help treat lung fibrosis by affecting certain immune cells.